Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Poliorix in Chinese Infants
NCT01021293Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2009
- Primary completion
- Jul 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Poliorix in poliomyelitis (2 arms), sponsored by GSK. Primary endpoint: Number of Seroprotected Subjects Against Poliovirus Types 1, 2 and 3 at Month 3. Started Nov 2009; status: completed.
02
Drugs
Poliorix
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT01021293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01021293.